GOLDEN VALLEY, Minn.- A groundbreaking gene study could change the way doctors screen for certain cancers and revolutionize prevention.
The Mayo Clinic's Dr. Ellen Goode joined KARE 11 News @4 to explain more about this landmark study.
250-thousand people were included in the study which was researched by more than a 100 institutions. Genes have been identified that tell people whether or not they are at increased risk for breast, ovarian, and prostate cancer.
The researchers found nearly fifty new markers for breast cancer, twenty-six for prostate cancer and nearly a dozen for ovarian cancer.
Experts say the new genetic information could lead to improved screening practices in the next decade, and new drugs to treat these cancers.